CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (14,973,000)	$ (4,181,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization, including amortization of capitalized loan costs	26,853,000	27,971,000
Share-based compensation expense	1,088,000	858,000
Impairment of real estate investments	9,700,000	0
Provision for bad debt	288,000	301,000
Non-cash casualty loss	990,000	347,000
Amortization of debt premiums and discounts	356,000	409,000
Other, net	(186,000)	102,000
Changes in other assets and liabilities:
Other assets	282,000	878,000
Accounts payable and accrued expenses	(2,975,000)	(1,256,000)
Net cash provided by operating activities	21,423,000	25,429,000
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from insurance	417,000	177,000
Payments for improvements of real estate investments	(5,316,000)	(5,042,000)
Other investing activities	(124,000)	(20,000)
Net cash used by investing activities	(5,023,000)	(4,885,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on mortgages payable	(1,567,000)	(1,906,000)
Proceeds from revolving lines of credit	25,255,000	44,893,000
Principal payments on revolving lines of credit	(29,750,000)	(43,519,000)
Distributions paid to common shareholders	(12,904,000)	(12,443,000)
Distributions paid to Series D preferred unitholders	(57,000)	(160,000)
Distributions paid to noncontrolling interests – Operating Partnership and Series E preferred units	(2,230,000)	(2,266,000)
Payments related to tax withholding for share-based compensation	(423,000)	0
Other financing activities	(110,000)	(212,000)
Net cash used by financing activities	(21,786,000)	(15,613,000)
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(5,386,000)	4,931,000
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD	15,651,000	13,129,000
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	10,265,000	18,060,000
SUPPLEMENTARY SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	1,446,000	1,821,000
Distributions declared but not paid to common shareholders	13,624,000	13,633,000
Retirement of shares withheld for taxes	0	292,000
Involuntary conversion of assets	(1,014,000)	(463,000)
Non-cash interest income	457,000	413,000
Unrealized gain on investment	209,000	67,000
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	9,532,000	8,640,000
Balance Sheet Description
Cash and cash equivalents	7,555,000	11,916,000
Restricted cash	2,710,000	6,144,000
Total cash, cash equivalents, and restricted cash	10,265,000	18,060,000
Operating Partnership Units
SUPPLEMENTARY SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Operating partnership/ Series E preferred units converted to common shares	811,000	335,000
Series E Preferred Units
SUPPLEMENTARY SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Operating partnership/ Series E preferred units converted to common shares	$ 365,000	$ 14,000